|
Aug 14
|
4 Medical Product Stocks to Watch From a Challenging Industry
|
|
Aug 12
|
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why
|
|
Aug 12
|
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know
|
|
Aug 9
|
BioLife Solutions Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 8
|
3 Stocks That May Be Trading Below Estimated Value In August 2025
|
|
Aug 8
|
Ligand Pharmaceuticals Among 3 Stocks Possibly Trading Below Intrinsic Value Estimates
|
|
Aug 7
|
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
|
|
Aug 7
|
BioLife Solutions Reports Second Quarter 2025 Financial Results
|
|
Aug 6
|
3 Stocks Estimated To Be Trading At A Discount Of Up To 49.4%
|
|
Aug 6
|
3 Stocks Estimated To Be Trading At Up To 49.3% Below Intrinsic Value
|
|
Aug 1
|
3 Stocks Estimated To Be Trading Up To 30.3% Below Intrinsic Value
|
|
Aug 1
|
3 Companies Including Zscaler That May Be Priced Below Estimated Value
|
|
Jul 31
|
3 Stocks Estimated To Be Up To 29.0% Below Intrinsic Value Offering Investment Opportunities
|
|
Jul 31
|
3 Stocks Possibly Trading Below Their Estimated Value By Up To 44.5%
|
|
Jul 28
|
Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations
|
|
Jul 28
|
BioLife Solutions Makes Strategic Investment in Pluristyx
|
|
Jul 24
|
BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025
|
|
Jul 23
|
3 Stocks Possibly Trading At Discounts Of Up To 46.4%
|
|
Jul 23
|
July 2025's Noteworthy Stocks Trading Below Estimated Fair Value
|
|
Jul 18
|
3 Stocks Estimated To Be Trading At Discounts Of Up To 29.5%
|